Adamas says lead drug meets late-stage study goals

(Reuters) - Drugmaker Adamas Pharmaceuticals Inc said its lead experimental drug met the main goal of a late-stage study.

http://ift.tt/1Th8DQQ

from Reuters: Health News
via animenewspro